United Kingdom· GB-APID-37287311000001105
Ledaga 160micrograms/g gel
A chlormethine product containing chlormethine, registered in United Kingdom by Recordati Rare Diseases UK Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Chlormethine is registered in 12 of 19 countries.
Countries holding a registration under ATC L01AA05 (chlormethine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Chlormethine · ATC L01AA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Chlormethine
- Manufacturer
- Recordati Rare Diseases UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01AA05
- ATC class
- Chlormethine
- Defined daily dose
- 0.16 mg, T
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin15099471001236
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
127 interactions on record for chlormethine.
Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chlormethine · interactions on record
127 records
- 32 severe
- 78 moderate
- 17 minor
Most severe, free to view
- Nalidixic acidJ01MB02severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Chlormethine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaLEDAGARECORDATI RARE DISEASES CANADA INC
- BelgiumLedaga 160 µg/gHelsinn Birex Pharmaceuticals
- SwitzerlandLedaga
- CzechiaLEDAGAHelsinn Birex Pharmaceuticals Ltd., Dublin
- SpainLEDAGA 160 MICROGRAMOS/G GELHelsinn Birex Pharmaceuticals Limited
- FinlandLedagaHelsinn Birex Pharmaceuticals Ltd
- FranceLEDAGA 160 microgrammes/g, gelHELSINN BIREX PHARMACEUTICALS
- IrelandLedaga 160 micrograms/g gelHelsinn Birex Pharmaceuticals Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ledaga
- Liechtenstein · Ledaga
- Norway · Ledaga
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bff3d38e-ee01-4cb6-8a50-86d96a43875d GET /v1/drugs/bff3d38e-ee01-4cb6-8a50-86d96a43875d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37287311000001105",
"desc": "Ledaga 160micrograms/g gel (Recordati Rare Diseases UK Ltd)",
"form": "Cutaneous gel",
"vpid": "37293111000001101",
"source": "dmd",
"vtm_id": "775175005",
"strength": "160 microgram",
"substance": "Chlormethine",
"ingredient": "Chlormethine hydrochloride",
"supplier_code": "3371801000001103"
}See everything about chlormethine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.